Authors: Muhammad Afzal Pechuho, Shahid Jamal Siddiqui, Syed Imtiaz Ali Shah, Raj Kumar
Abstract
To evaluate trabeculectomy with Mitomycin – C as primary surgery in
congenital glaucoma. Design: Prospective , non randomized hospital based descriptive study, review of all cases of congenital glaucoma that underwent trabeculectomy with Mitomyicin-C as primary surgery between 2006 to 2008. Patients And Methods: A total number of 40 eyes of 30 patient with congenital glaucoma, who underwent primary trabeculectomy with MMC were included. Preoperative and postoperative intraocular pressures (IOP), corneal clarity, diameter, axial length, successful outcomes for survival analysis were measured. IOP<21mmHg with one topical medication and complications were evaluated in this study. Result: Patients age at surgery ranged from 15 days to 10 years, the mean age was 56.37 months. Mean preoperative IOP was 33.26 ± 7.28mmHg and mean postoperative IOP was 17.1mmHg, pre and post operative IOP differences were significant at all examination periods (P<0.001). The mean follow-up was 1-36 months complete success was achieved in 22 eyes (55.0%) and qualified success was in 11 eyes (27.5%). Complications included hypotony, wound leak and hyphaema. Conclusions: Antimetabolite augmentation of filtration surgery appear to give favorable out comes in the treatment of primary congenital glaucomas. There were no major or sight-threatening complications in our series.
Keywords: Trabeculectomy, Mitomycin-C, Congenital Glaucoma.
